Drug Development

Home » Drug Development

LATEST NEWS

New Partnership: TransCure bioServices and Preclina Inc Join Forces to Expand Collaboration
June 5, 2023
What Can We Do For You: New CDX Models for AML Studies
December 27, 2022
TransCure bioServices Improves Its Services with 3D Tumor Imaging from Biovolume
December 14, 2022
TransCure bioServices Welcomes Cathay Capital to Accelerate Its Ambitious Growth
June 29, 2022

Neve | Powered by WordPress

BIO BLOG

How do laboratory mice live?
April 2, 2024
How to Effectively Assess the Well-being of Laboratory Mice
February 14, 2024
Deciphering the Global Challenge of Liver Cancer: Pathophysiology, Advances in Treatment and in vivo Preclinical Mouse Models
December 4, 2023
Modeling NAFLD in Humanized Mice: Upgrading Preclinical Research to Make a Difference in The Search for Innovative Therapies
October 16, 2023
Advancing NASH Preclinical Research with Humanized Mouse Models for Innovative Therapeutics
October 6, 2023

WEBINARS & EVENTS

EASL 2024: Advancing Liver Research
Milan, Italy June 5-8, 2024
BIO-US 2024
San Diego, California June 3-6, 2024
BIO-Europe Spring 2024
Barcelona, Spain March 18-20, 2024
7th Annual CAR-TCR Summit Europe
London, United Kingdom February 27-29, 2024
Next-Gen Immuno-Oncology Conference – West Coast Edition
San Diego, California USAFebruary 8-9, 2024
Advancing Oncology: TransCure bioServices Showcases Innovations at 3rd Global Cancer Consortium Conference
Navi Mumbai, IndiaFebruary 3-5, 2024

CONTACT INFO

ArchParc, Le Forum 1
260, av. Marie Curie
74160 Archamps, France

Phone:
+33 4 80 16 01 42
(Customer inquiries only please, no solicitation)

NEWSLETTER
CAREERS
TERMS of USE
LEGAL NOTICES
PRIVACY POLICY
COOKIE POLICY
SITE MAP